share_log

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $82

Benzinga ·  May 8 10:43

Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and lowers the price target from $85 to $82.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment